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Abstract 
The asthma therapeutic theophylline exists in at least three anhydrous polymorphs and a 
monohydrate. The single-crystal X-ray structure of the high-temperature polymorph form I is 
presented for the first time and the energetic relationship between forms I and II is investigated 
using the partial charges and chemical hardness analysis (PACHA) algorithm. It is shown that the 
interactions in the form I crystal network are stronger, especially the hydrogen bond. The single-
crystal neutron structure of the monohydrate demonstrates static disorder of the water molecule as 
well as dynamic disorder of the methyl groups. PACHA investigations based on the neutron 
coordinates reveal that the homomeric interactions in this form are stronger than the interaction of 
the water with the host molecules. The dehydration of the hydrate should thus leave the 
theophylline network intact, explaining the isomorphic powder X-ray diffractograms of the 
monohydrate and its dehydrated form III.  
 
Keywords: Hydrate, neutron diffraction, polymorphism, lattice-energy calculation, Laue diffraction 
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Introduction 
Polymorphism, the phenomenon of different crystal forms occurring for a specific molecule, has 
been known for nearly 200 years.1 Different crystal forms can vary widely in their physico-chemical 
characteristics, such as melting point, solubility, chemical and physical stability. This variation can 
prove problematic especially in pharmaceutical compounds, because it can cause processing 
problems, instability in the final formulation or influence the drug’s bioavailability because of the 
differing solubility of different polymorphic forms.2-5 The choice of the wrong crystal form thus 
causes severe problems and can cost the pharmaceutical company large amounts of money in 
‘damage limitation’.6,7 
In additional to ‘pure’ polymorphs, crystals may contain solvent of crystallisation resulting in various 
solvate forms, or hydrates in the special case of the inclusion of water.8 The incorporated solvent can 
vary in its interaction with the host molecules in the crystal and exhibit varying stability towards 
desolvation. Moreover, solvates show the lowest solubility in the solvent they incorporate.9 In the 
case of hydrate formation of drugs this can have considerable effects on the bioavailability of the 
compound, as all medicines need to ultimately dissolve in aqueous human or animal body fluids. 
There is considerable current interest in the study of water clusters in crystalline hydrates in order to 
understand the homomeric and heteromeric interactions of the water and the host molecules.8,10-14 
It is increasingly apparent that many compounds can exist in more than one crystal form and 
identification and analysis of every form (particularly the thermodynamically stable form under a 
given set of conditions)15 is essential for manufacturing, storage and intellectual property 
considerations.3,16 Discovery of the full range of crystal forms of any given compound is usually time-
consuming and expensive, and even after extensive screening it is difficult to be certain that the 
process is complete and every possible form has been identified. In this regard, computational 
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crystal-structure prediction is a useful and fast-growing field,17 and has developed from small rigid 
compounds to more complex multi-component systems like hydrates.18,19 Moreover novel 
approaches such as supramolecular gel crystallization can increase the chance of discovering the 
difficult-to-nucleate solid forms.20 However, without experimentally obtained crystal structures, 
computational ab initio prediction cannot be validated and the factors governing the stability of a 
particular solid form cannot be understood. In this study we report the structure of the elusive high-
temperature form I of the well-known drug theophylline and probe its relationship with the room 
temperature form II by ab initio lattice energy calculations based on the crystallographic coordinates 
obtained by X-ray and neutron crystallography.  
Theophylline (THEO, Figure 1) has been known since 1888,21 when it was first extracted from tea 
leaves, and it has been in pharmaceutical use since 1902. THEO is a strong bronchospasmolyticum 
and bronchodilatator, and is mainly used as a treatment of bronchial asthma. The compound is listed 
in both the European22 and the United States Pharmacopoeia,23 and the drug and its solid-state 
properties are still very much in the focus of pharmaceutical research. In crystal-engineering studies 
THEO is a popular model compound used to explore polymorphism and especially hydrate 
formation.24-27 
THEO is reported to crystallise in four different crystal forms. The anhydrous form I is the high-
temperature polymorph which is thermodynamically the most stable form above 232 ˚C.28 Form II is 
enantiotropically related to form I and is the stable polymorph at room temperature.29,30 The crystal 
structure of this latter form has been solved in the orthorhombic space group Pna21.
31,32 The crystal 
structure of the monohydrate has also been determined and found to be monoclinic, although two 
space groups (P21 and P21/n) have been reported.
33,34 Upon dehydration under reduced pressure, 
the monohydrate converts to a third anhydrous crystal form variously named either form I* or form 
III.35,36 The powder X-ray diffractogram of this third form is closely related to the XRPD pattern of the 
monohydrate. In addition to these crystal forms, THEO readily forms a range of other co-crystals and 
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is commonly studied as a co-crystal former.37-42 Recently, a new anhydrous form IV has been 
reported.43,44 However, reproduction of this form following the published procedure of slurry 
conversion in methanol failed in our hands. Another crystal form has been reported to be obtained 
by antisolvent precipitation using supercritical CO2 and CHF3 as antisolvent.
45 The authors suggest 
the new form to be related to the room temperature polymorph form II but distorted and 
crystallising in a monoclinic rather than orthorhombic symmetry.46 This new crystal phase has also 
been found in theophylline crystallised from methanol or nitromethane, which is pure form II when 
investigated by powder X-ray diffraction. However, electron microscopy and electron diffraction 
reveals the existence of the new polymorph as micro-impurity.47 
In the present work we report the single-crystal neutron structure of theophylline monohydrate and 
lattice-energy calculations of the hydrate as well as the anhydrous forms I and II using the PACHA 
algorithm.48 The aim is to rationalise the thermodynamic stability and mutual interconversion of the 
THEO crystal forms using non-empirical energy calculations based on the experimental crystal-
structure coordinates. 
 
Figure 1 Theophylline molecular structure and numbering scheme used in the crystal structure. 
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Results and Discussion 
Crystal structure analysis of the polymorphic forms I and II 
The high-temperature polymorph form I of theophylline was described by Burger and Ramberger in 
197929 but structural data have never been published.49 We have succeeded in crystallising single-
crystals of sufficient size for X-ray structural analysis from the melt at temperatures above 270 ˚C, 
where form I grows slowly as large prismatic crystals. These undergo considerable cracking upon 
cooling but a sufficiently large intact part of the melt film could be extracted for structure analysis. 
The crystallographic data are listed in Table 1. 
 
Table 1 Crystallographic data for the three crystal forms of theophylline studied.  
Form I II monohydrate 
 X-ray X-ray Neutron Laue diffraction 
Formula C7H8N4O2 C7H8N4O2 C7H8N4O2 C7H8N4O2  
   · H2O · H2O  
Mr 180.17 180.17 198.19 198.19  
Crystal system orthorhombic orthorhombic monoclinic monoclinic  
Space group Pna21 Pna21 P21/n P21/n  
T (K) 120(2) 120(2) 120(2) 20(2)  
a (Å) 13.087(2) 24.330(1) 4.4605(3) 4.4159(3)
a
 
b (Å) 15.579(3) 3.7707(2) 15.3207(9) 15.1675(9)
a
 
c (Å) 3.8629(6) 8.4850(5) 13.0529 (7) 12.9224(7)
a
 
α (°) 90 90 90 90 
β (°) 90 90 97.511(2) 97.511(2) 
γ (°) 90 90 90 90 
V (Å
3
) 787.6(2) 778.43(8) 884.36(9) 858.09(9) 
Z 4 4 4 4 
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density (calc, g/cm
-3
) 1.520 1.537 1.488 1.534 
wavelength (Å) 0.71073 0.71073 0.8 – 5.2 0.8 – 5.2 
abs. coef (mm
-1
) 0.116 0.118   
F(000) 376 376 256 256 
crystal size (mm
-3
) 0.32 x 0.18 x 0.09 0.98 x 0.14 x 0.08 2.0 x 0.5 x 0.4 2.0 x 0.5 x 0.4 
θ range for  
   data collection 2.03 – 29.34 1.67 – 30.03   
index ranges -18 < h < 18 -34 < h < 34 -5 < h < 7 -6 < h < 7 
 -21 < k < 14 -5< k <5 -23 < k < 24 -23 < k < 24 
 -5 < l < 5 -11 < l < 11 -21 < l < 20 -20 < l < 20 
reflections collected 6379 9220 5267 4390 
independent 
   reflections 2139 2267 1549 1519 
refinement method  full-matrix least-squares on F
2
 
data/restraints/ 
   parameters 2139/1/124 2267/1/124 1549/0/231 1519/0/205 
goodness of fit 
   on F
2
 0.972 0.955 1.155 2.065 
final R indices R1 = 0.0786 R1 = 0.0416 R1 = 0.0836 R1 = 0.1620 
   [I>2σ(I)] wR2 = 0.1934 wR2 = 0.0976 wR2 = 0.1731 wR2 = 0.4491 
R indices (all data) R1 = 0.1130 R1 = 0.0569 R1 = 0.0967 R1 = 0.1659 
 wR2 = 0.2118 wR2 = 0.1035 wR2 = 0.1741 wR2 = 0.4494 
largest diff peak 
   and hole [eÅ
-1
/fmÅ
-3
] 0.311 and -0.317 0.228 and -0.251 1.305 and -1.238 3.038 and -3.114 
a Cell dimensions of the monohydrate structure at 20K are calculated from the cell at 120K with an 
isotropic shrinking of 1%. 
Form I crystallises in the orthorhombic space group Pna21 with one molecule in the asymmetric unit 
(Z’ = 1). The THEO molecule itself is planar, with the methyl substituents in plane with the purine 
ring. One short hydrogen bond can be detected involving the NH group of the five-membered ring of 
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one molecule (N4-H4) as donor and a carbonyl group of the six-membered ring of the next molecule 
as acceptor (C2=O2). Due to this interaction, which connects functional groups on opposite ends of 
the molecule, the resulting hydrogen-bonded chains connect the THEO molecules like a chain of 
beads on a string in the (2 0 1) and the (-2 0 1) planes. The hydrogen-bonded chains π···π-stack on 
top of each other with a distance of 3.37 Å (a typical distance for this type of compound)50 resulting 
in layers within the structure having the same orientation, with successive layers related through the 
21 screw axis (Figure 2).  
 
 
Figure 2 Packing of THEO forms I and II. Each hydrogen bonded chain has its individual colour, 
hydrogen atoms have been omitted for clarity. 
 
To facilitate comparison, the previously reported crystal structure of form II31,32 was redetermined at 
120 K from crystals grown by sublimation at 458 K. Form II also crystallises in the orthorhombic 
spacegroup Pna21 and has the planar THEO molecule in the same conformation as form I so that 
these two polymorphs are an example of packing polymorphism, as opposed to conformational 
polymorphism.51 Form II like form I shows only one significant hydrogen bond, which in this crystal 
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form connects from the same donor (N4-H4) to the second nitrogen atom of the five-membered ring 
of the purine (N3). This different hydrogen bond causes the hydrogen-bonded chains to adopt a 
zigzag shape (Figure 2). Enclosing the b-glide plane, the chains themselves are not planar in contrast 
to those found in form I and subtend an angle of 134.5˚ between directly connected molecules. As in 
form I the hydrogen-bonded chains π···π-stack on top of each other with a distance of 3.37 Å, 
resulting in layers along the b-axis. Neighbouring layers are generated through the 21-screw 
operation. 
 
Energy calculations of the polymorphs 
Crystals of sufficient size and quality for single-crystal neutron diffraction could not be grown of 
either of the anhydrous crystal forms, and hence the coordinates of the X-ray structures were 
utilised for the non-empirical energy calculations using the PACHA algorithm.48 Since the hydrogen-
atom positions of these structures suffer from the usual X-ray distortion, all hydrogen atoms were 
added in calculated positions with optimised bond lengths52 and their position subsequently 
optimised sterically and electrostatically. The PACHA algorithm is a fast, ab initio method that treats 
atoms as point charges and is thus a simple approximation to the calculation of lattice energies 
compared to the high-level algorithms used for polymorph prediction.53-56 Therefore, the values 
derived from PACHA cannot be taken as absolute, because small changes in the treatment of the 
atomic partial charges, as implemented in other algorithms, could have great influence on the 
resulting calculated lattice energies. However, this simplification allows calculations to be performed 
within minutes rather than weeks, and thus PACHA presents itself as a rapid and efficient tool for 
the interpretation of crystal network energies. Due to its limitations, only the trends rather than 
absolute values are emphasised in the following discussion. For detailed information of the 
calculations refer to the supporting information. 
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Both form I and form II have motif 1 in common (see ESI figure S1 and S2), in which the theophylline 
molecules stack on top of each other interacting through cooperative π···π stacking and non-
cooperative short contacts of the methyl groups. The interaction energies are +4.1 kJ mol-1 for form I 
and +7.8 kJ mol-1 for form II. The difference in energy can be explained by the difference in distance 
in these stacks (3.86 Å for form I versus 3.77 Å for form II), which in the case of form II results in a 
stronger repulsion of the methyl groups and thus higher energy. 
The subsequent stacking of this basic motif 1 is quite different for the two polymorphs. In form I the 
basic stacks are packed along (0 1 0) with an interaction energy of -21.5 kJ mol-1 (motif 2). This value 
is the sum of two different interactions, one being a hydrogen bond between a methyl group and 
the carbonyl group of the next molecule, while a second hydrogen bond links the ring’s acidic C4-H4a 
to atom N3 on the next molecule. Finally, the stacks are connected through the conventional 
hydrogen bond (motif 3) linking N4-H4 with O2=C2 with an energy of -23.9 kJ mol
-1, which can be 
classified as a medium strength hydrogen bond.57 
The stacking of motif 1 in form II shows a second stacking motif along (0 0 1) with an interaction 
energy of -10.8 kJ mol-1 (motif 2). This interaction is cooperative due to hydrogen bonds between a 
methyl and a carbonyl group resulting in single hydrogen-bonded chains along the c-axis. In packing 
motif 3, these chains stack according to the a glide plane resulting in double chains. The interaction 
energy of –9.6 kJ mol-1 means that these chains are slightly less cooperative due to repulsive short 
interactions between methyl groups. These interactions are located in the (2 0 0) face of the platy 
crystals (see Figure S3 in ESI), which were found to show dislocation upon cutting and preparation 
for diffraction experiments. An explanation for this behaviour would be that the crystals show low 
resistance against shear forces and the layers can slide over each other easily. Motif 4 shows the 
hydrogen-bonded stacks of motif 1, which are cooperative with -13.7 kJ mol-1. Even though the 
values of the hydrogen bonding energies are not comparable, the relative energy of the hydrogen 
bond to the overall lattice energy is considerably lower in form II than in form I and thus the 
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hydrogen bond can be assumed to be weaker. This is explicable by the lower electronegativity of the 
acceptor nitrogen atom compared to that of oxygen. In addition, the hydrogen-bond in form I is 
shorter in comparison to that in form II (donor-acceptor distance 2.73 Å and 2.79 Å, respectively) 
even though the bond in form II is more linear than that in form I (bond angle of 174.6° vs. 154.6° 
based on the optimised hydrogen atom coordinates).  
The crystal structures and respective energies give an insight into the lack of interconversion 
between the two crystal forms of THEO despite their enantiotropic relationship. To transform form II 
into form I upon heating, not only the existing hydrogen-bond has to be broken but also the 
molecules have to rearrange significantly to reconnect into new hydrogen-bonded chains. This 
process resembles partial melting and has indeed been reported to take place only at higher 
temperatures and over the relatively long time of several hours.28 It is possible that this transition 
takes place via the gas phase, as THEO sublimes readily at higher temperatures, and although the 
sublimation product is normally form II, it is likely that above the transition temperature form I 
nucleates upon resublimation. The transition of form I to form II upon cooling is hindered again by 
the necessity of rearrangement on the molecular scale. In addition, the hydrogen bond to be broken 
is considerably stronger, so that the transition requires a very high activation energy unlikely to be 
provided at lower temperatures at which form II is the stable polymorph. 
Taking all calculations into account, the interactions of the 3D network in form I are stronger than 
those of form II. It is probable that form II is a faster growing crystal form than form I, as the 
interactions in this crystal form have lower energy and have a higher orientational freedom, as most 
interactions are single hydrogen bonds compared to the dimerisation in form I (motif 2).  
 
The monohydrate 
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Even though the monohydrate of theophylline has been extensively studied, no neutron crystal 
structure has been reported. Crystals of suitable size were grown by evaporation of an aqueous 
solution and Laue neutron diffraction data were measured on VIVALDI at the Institut Laue-Langevin 
(Grenoble, France).58 In order to obtain the most accurate structural model, the same crystals were 
initially submitted to X-ray diffraction and the structure redetermined at 120 K. Neutron Laue 
diffraction data were then collected at 120 K and at 20 K. Details of the two neutron structure 
refinements are listed in Table 1. 
 
Figure 3 Hydrogen bonding and packing diagram of the THEO monohydrate neutron structure at 
120 K. Ellipsoids are drawn at 50% probability. The water hydrogen atoms are disordered. 
 
As described by Sun et al.34 the theophylline monohydrate structure consists of theophylline dimers 
connected through an inversion centre. This results in the formation of two hydrogen bonds from 
N4-H4 to O1 with an H···O distance of 1.732(9) Å at 120 K and 1.762(19) Å at 20 K. In both cases 
these interactions are very directional with N-H···O angles of 167.9(8)° and 163.5(15)°, respectively. 
The distances correlate well with those described by Sutor,33 who found the N···O distance to be 
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2.76 Å (cf. 2.749(5) Å at 120 K and 2.757(10) Å at 20 K in the present work). This dimerisation is 
unique in the crystal structures of THEO and can be assumed to play a major role in the formation of 
the hydrate since it exposes the strongly basic nitrogen atom N3. The dimers are located in layers 
along the crystallographic a-axis, which show an interplanar distance of 3.26 Å and thus can be 
assumed to interact through π···π-stacking. No hydrogen bond exists between these layers. Along 
the b-axis, the THEO layers are separated through channels of water molecules, which interact with 
the THEO molecules through one hydrogen bond to N3 (Figure 3). These show a considerably longer 
H···O distance (1.932(10) Å at 120 K and 1.90(2) Å at 20 K) than the dimer interactions, while being 
equally linear (171.5(10)° and 172.7(18)°, respectively). It can be assumed that these bonds are 
weaker than the hydrogen bonds linking the dimeric units together. The second hydrogen atom of 
the water molecule is disordered over two positions with close to 50% occupancy on each position. 
Due to the orientation of the water molecules in the channel, they can hydrogen bond either along 
(1 0 0) or along (-1 0 0) with equal probability. Both possibilities of these hydrogen bonds have an 
H···O distance around 1.83 Å, with the exception of one hydrogen bond in the 120 K structure being 
considerably longer with 1.896(17) Å. All of these bonds are very directional with the bond angle 
well above 170°.  
An interesting feature of the monohydrate crystal structures is the disorder in both methyl groups. 
Sun et al. model one of the methyl groups as being statically disordered over two positions by 
rotation around the methyl carbon atom. The neutron structure at 120 K shows very large atomic 
displacement parameters (ADP) for the hydrogen atoms of both methyl groups (Figure 4), while both 
carbon atoms show normal ADPs. Modelling disorder of the hydrogen atoms over two or more sites 
as would result by static disorder of the methyl group by rotation about the C-C bond resulted in an 
unstable refinement. Upon cooling to 20 K, the ADPs of the methyl hydrogen atoms are still very 
large compared to the remaining atoms, but comparison to those of the 120 K structure reveal an 
overall reduction in size. This points towards dynamic disorder, which can be minimised by cooling of 
the crystal structure, and will finally contribute to the zero-point motion of the crystal form.  
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Figure 4 Comparison of the monohydrate structure at 120 K (lower) and at 20 K (upper) with the 
atomic displacement parameters of the two methyl substituents. 
 
Energy calculations of the monohydrate 
The basic motif in the monohydrate is the dimer of THEO molecules (see ESI figure S4), which 
furthermore are only interacting with another THEO molecule through C-H···O hydrogen bond and 
with the water molecules. The hydrogen bond in these dimers could be calculated to have an energy 
of -15.2 kJ mol-1, thus the total interaction energy of the dimers is -30.4 kJ mol-1. This interaction 
energy represents a large amount of the overall lattice energy and is higher than the relative 
contributions of the hydrogen bonds found in the anhydrous forms I and II. It is thus surprising that 
the dimer is not the most common motif. Only surprisingly low energetic interactions can be found 
between these dimers, with the strongest being the C-H···O interaction, which is calculated to have 
an energy of -2.9 kJ mol-1, due to the long distance of 2.09 Å (hydrogen to acceptor).  
Due to the disorder in the water molecules only an average interaction energy for the homomeric 
hydrogen bond can be determined. However, at -33.5 kJ mol-1, this interaction is relatively strong, 
although still moderate on Jeffrey’s scale.57 The heteromeric interaction has an energy of -20.3 
(H2W) and -23.2 kJ mol-1 (H3W), values that are higher than the values found by Suihko et al. by 
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molecular modelling using semi-empirical chemical calculations on an optimised model of the X-ray 
crystal structure of the monohydrate (12.4 kJ mol-1).59 However, they are considerably lower than 
the homomeric interaction energies of the monohydrate. It can be assumed that upon dehydration 
of the monohydrate, the whole channel clears at once, as the interaction to the host is broken more 
easily than the homomeric interaction in the water. The resulting dehydrated form would be 
structurally very closely related to the hydrate, as the THEO dimers remain undisturbed due to the 
higher homomeric hydrogen-bonding strength. Such dehydration behaviour is reported for drying 
the THEO monohydrate at low pressure and room temperature to obtain the metastable anhydrous 
form III, which was found to have a very similar NIR spectrum and powder X-ray diffractogram to the 
hydrate.60 Amado et al. even postulate that form III is the direct dehydration product of the 
monohydrate at any temperature and ambient pressure,61 which would corroborate our hypothesis 
of its dimeric structure. The dehydrated form III is reported to undergo rapid transition to form II. 
This would be understandable because of the destabilising voids left in the crystal structure due to 
the removal of the water molecules. In addition, the THEO molecules in form III would only be 
stabilised through very weak interactions other than the dimers, while form II shows a more 
stabilising crystal network. 
The neutron structure of the monohydrate at 20 K reveals that most of the interactions become 
stronger according to the PACHA calculations. Especially interesting is the decrease of the THEO 
dimer hydrogen-bonding energy by 12 kJ mol-1 to -27.1 kJ mol-1. In combination with the very strong 
homomeric water hydrogen bond of -38.6 kJ mol-1 and the almost unchanged THEO-water 
interaction of -22.6 and -22.4 kJ mol-1, the homomeric interactions become more pronounced. These 
results imply that the dehydration and conservation of the dehydrated crystal structure should be 
energetically more favoured at lower temperatures, as the interaction between the water and the 
host molecules weakens. To prove this, dehydration at lower pressures and low temperature would 
have to be performed, which is to be followed up in future studies. 
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Conclusion 
The single-crystal X-ray structure of theophylline high temperature form I is reported and 
comparison to the known structure of form II shows that the crystal form is stabilised by different 
hydrogen bonds and the overall packing changes. Thus these two crystal forms are packing 
polymorphs.51 The neutron structure of the monohydrate at 120 K and 20 K verifies the described 
disorder of one water hydrogen atom position, while the disorder in the methyl groups was found to 
be of dynamic nature. Lattice energy calculations based on the structural models reveal that the 
hydrogen bonding energies in the two anhydrous polymorphs vary considerably, as was found for 
the stabilising packing energies. The hydrogen bonds between the THEO molecules were found to be 
stronger in form I than in form II. The low conversion rate of form II to form I at higher temperatures 
can thus be explained by the necessity to break this moderate hydrogen bond and a complete 
rearrangement of the crystal packing. The reverse transformation has not been observed yet, and 
can be explained by the necessity to break an even stronger hydrogen bond at lower temperatures, 
at which it is unlikely to overcome the activation energy of the transition. 
The energy calculations on the monohydrate reveal strong homomeric interactions in the water 
channels and for the theophylline dimers, while the interaction between the two species is 
comparably weak. From this information the dehydration behaviour can be rationalised and the 
structure of form III assumed as having the same dimer structure as the monohydrate. The different 
energies also help to explain the low stability of the hydrate, as only medium interactions have to be 
overcome to release the incorporated water from the structure. Our neutron single-crystal structure 
study also cleared the case beyond doubt of disordered hydrogen atom positions in the water 
molecule to be of static nature, while the hydrogen atoms of the methyl groups are dynamically 
disordered. 
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The combination of neutron structures with non-empirical lattice energy calculations proves to be a 
valuable tool to understand the relationship between crystal structures and results in accurate 
hydrogen bonding and packing energies. This information is not only improving our understanding of 
polymorphic and solvated crystal structures but also is essential for designing accurate models for 
polymorph prediction. 
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Experimental 
Materials 
Theophylline was purchased from Sigma-Aldrich and used without any further purification. Form I 
crystals were crystallised from the melt above 270 °C. Form II crystals were obtained by slow 
sublimation at 120 °C, while the monohydrate was crystallised by evaporation to dryness of a 
saturated water solution at room conditions. 
Methods 
Slurry conversion of THEO form II in methanol 
An amount of 500 mg pure form II was slurried in 10 ml of methanol (p.a. standard), stirred at 600 
rpm, and characterised daily by Attenuated Total Reflection infrared spectroscopy (Spectrum 100, 
Perkin Elmer, Cambridge, UK). No conversion was detected after 18 days. 
X-ray single-crystal diffraction 
Single-crystals of all three crystal forms suitable for structure determination were selected, soaked in 
perfluoropolyether oil and mounted on Mitegen sample holders. Crystallographic measurements 
were carried out at 120K using a Bruker SMART CCD 6000 single-crystal diffractometer equipped 
with an open-flow N2 Cryostream (Oxford cryosystems) device using a graphite monochromated 
MoKα radiation (λ= 0.71073Å). For data reduction, the SAINT suite was used, the structures were 
solved with SHELXS62 and refined with SHELXL62. All non-hydrogen atoms were treated 
anisotropically, the hydrogen atoms connected to carbon atoms were added in calculated positions 
and refined isotropically as riding models. The hydrogen atom bound to the nitrogen was located 
from the Fourier maps and refined isotropically.  
Neutron single-crystal diffraction 
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A single-crystals of the monohydrate of the size of 2 x 0.5 x 0.4 mm3 was mounted on a V pin with 
vacuum grease and placed in a helium-flow cryostat on the Very-Intense Vertical-Axis Laue 
Diffractometer (VIVALDI)58 at the Institut Laue-Langevin, Grenoble, France. Data were collected from 
the stationary crystal at 120 K and 20 K using a white neutron beam with wavelengths between 0.8 
and 5 Å. The crystal was rotated 20° between patterns, which were recorded in exposures of 90 
minutes. The patterns were indexed using the program LAUEGEN63,64 and the reflections integrated 
using the local program INTEGRATE+65 and normalised to a common incident wavelength using the 
program rearrange. Correction for absorption was deemed unnecessary in view of the small sample 
volume. The obtained dataset was then refined against the model obtained by X-ray diffraction using 
SHELXL.62 Since only relative unit-cell lengths can be determined by Laue technique, the unit cell at 
20 K was estimated by assuming a decrease in each cell axis from 120 K of 1%. All atoms were 
refined anisotropically. 
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The asthma therapeutic theophylline exists in three anhydrous polymorphs and a monohydrate. The 
energetic relationship between forms I and II is investigated using the partial charges and chemical 
hardness analysis (PACHA) algorithm. PACHA investigations based on the neutron single crystal 
structure of the monohydrate reveal that the homomeric interactions are stronger than those of the 
water with the host molecules. 
